Citation Impact
Citing Papers
p53: puzzle and paradigm.
1996 Standout
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review
1995
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast Cancer
1999
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Prognostic Factors in Breast Cancer
2000
Mdm2 promotes the rapid degradation of p53
1997 StandoutNature
Mitotic Checkpoint Inactivation Fosters Transformation in Cells Lacking the Breast Cancer Susceptibility Gene, Brca2
1999 StandoutNobel
Prognostic Factors in Node-Negative Breast Cancer
2002
Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis
1997
Detection of Breast Cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry
2001
Cancer to bone: a fatal attraction
2011 Standout
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
2003 Standout
Occult axillary lymph node metastases in “node-negative” breast carcinoma
1993
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis
1989
Prognostic factors in early breast carcinoma
1994
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up
1994
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
1992
Obvious peritumoral emboli: an elusive prognostic factor reappraised. Multivariate analysis of 1320 node-negative breast cancers
1998
The fate of bone marrow micrometastases in patients with primary breast cancer.
1989
Pathological prognostic factors in breast cancer
1999 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis
2000
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer
1988
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Lymphatic Invasion, Tumor Size, and Age Are Independent Predictors of Axillary Lymph Node Metastases in Women With T1 Breast Cancers
1999
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
p53 function and dysfunction
1992 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Bone marrow micrometastases in breast cancer patients
1999
Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients
1991
Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma
1991
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
1999
The Ki-67 protein: From the known and the unknown
2000 Standout
Oncofetal reprogramming in tumour development and progression
2022
Mechanisms of Bone Metastasis
2004 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up
1994
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
PREDICTION OF ENDOCRINE RESPONSE IN BREAST CANCER BY IMMUNOCYTOCHEMICAL DETECTION OF OESTROGEN RECEPTOR IN FINE-NEEDLE ASPIRATES
1987
Breast cancer metastasis: markers and models
2005 Standout
Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
2000
Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game
2002
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Clinical Prediction Rules
1985 Standout
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
1994 StandoutScience
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease
1979 Standout
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
1993 Standout
[Colorectal cancer in ulcerative colitis].
2014
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
1999
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis
1986
Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis
1985
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Clinical correlation between CEA and breast cancer
1978
Measuring the Accuracy of Diagnostic Systems
1988 StandoutScience
Evidence-Based Medicine
1992 Standout
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
1978 Standout
In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy
2006
p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
1992
Prognostic importance of occult axillary lymph node micrometastases from breast cancers
1990
Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer
1985
COAGULATION DISORDERS IN CANCER
1996
Biological markers in breast carcinoma:III. Clinical correlations with carcinoembryonic antigen
1977
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
1993
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
2003
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy
1998
Response of Circulating Tumor Cells to Systemic Therapy in Patients With Metastatic Breast Cancer: Comparison of Quantitative Polymerase Chain Reaction and Immunocytochemical Techniques
2000
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
2003
Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor
2006
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of R Bettelheim being referenced
Role of Plasma Carcinoembryonic Antigen in Diagnosis of Gastrointestinal, Mammary, and Bronchial Carcinoma
1972
Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer
1991
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.
1992
Recurrent, Isolated Factor X Deficiency in Myeloma: Repeated Normalization of Factor X Levels after Cytostatic Chemotherapy Followed by Late Treatment Failure Associated with the Development of Systemic Amyloidosis
1992
Effects of endocrine therapy on steroid-receptor content of breast cancer
1982
Prognostic significance of peritumoral vascular invasion in breast cancer
1984
Immunocytochemistry in the identification of vascular invasion in breast cancer.
1984
The Relationship Between Micrometastases in the Bone Marrow, Histopathologic Features of the Primary Tumor in Breast Cancer and Prognosis
1988